Cargando…
Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics
The enormous and thin alveolar epithelium is an attractive site for systemic protein delivery. Considering the excellent biocompatibility of phospholipids with endogenous pulmonary surfactant, we engineered dimyristoylphosphatidylcholine (DMPC)-based liposomes for pulmonary administration, using Cy5...
Autores principales: | Ponkshe, Pranav, Wang, Yingzhe, Tan, Chalet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383297/ https://www.ncbi.nlm.nih.gov/pubmed/37514138 http://dx.doi.org/10.3390/pharmaceutics15071951 |
Ejemplares similares
-
Combined Delivery of Paclitaxel and Tanespimycin via Micellar Nanocarriers: Pharmacokinetics, Efficacy and Metabolomic Analysis
por: Katragadda, Usha, et al.
Publicado: (2013) -
Liposomal Delivery of MIW815 (ADU-S100) for Potentiated STING Activation
por: Ji, Nan, et al.
Publicado: (2023) -
Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies
por: Tan, Chalet, et al.
Publicado: (2013) -
Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
por: Rudokas, Mindaugas, et al.
Publicado: (2016) -
Inhalational System for Etoposide Liposomes: Formulation Development and In Vitro Deposition
por: Parmar, J. J., et al.
Publicado: (2011)